Page last updated: 2024-08-24

fadrozole and tamoxifen

fadrozole has been researched along with tamoxifen in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.35)18.7374
1990's11 (47.83)18.2507
2000's9 (39.13)29.6817
2010's1 (4.35)24.3611
2020's1 (4.35)2.80

Authors

AuthorsStudies
Bogart, MH; Lance, VA1
Hayashi, K; Kosaki, G; Shimozuma, K; Tominaga, T; Yoshida, Y1
Bhatnagar, AS; Matter, A; Schieweck, K1
Brodie, A; Savinov, A; Wang, J; Yue, W1
Chinchilli, VM; Demers, L; Grossberg, H; Harvey, H; Konrad, K; Leitzel, K; Lipton, A; Teramoto, Y; Volas, G1
Bonnefoi, HR; Coombes, RC; da Luz, RJ; Dowsett, M; Houston, SJ; Powles, TJ; Rubens, RD; Smith, IE; Trunet, PF1
Buzdar, AU; Hortobagyi, GN; Plourde, PV1
Falkson, CI; Falkson, HC1
Bacchi, M; Beretta, K; Castiglione-Gertsch, M; Cavalli, F; Fey, M; Goldhirsch, A; Jungi, WF; Löhnert, T; Senn, HJ; Thürlimann, B1
Deguchi, J; Higuchi, K; Karasawa, M; Matsuda, A; Miyamoto, M; Yoneyama, S1
Tominaga, T1
Dowsett, M1
Kimura, M; Nomura, Y; Ohashi, Y; Takashima, S; Toge, T; Tominaga, T1
Chang, CF; Du, JL; Dufour, S; Huang, JD; Lee, CY; Lee, YH; Sun, LT; Yen, FP1
Kurebayashi, J; Sonoo, H1
Hirayama, K; Nakajima, Y; Nishiyama, S; Saitoh, K; Shimada, T; Shimizu, T; Terashima, H1
Buzdar, AU1
Babiak, I; Bopopi, JM; Kestemont, P; Leprieur, F; Mandiki, SN1
Krishnamurthy, HN; Moudgal, NR; Ramachandra, SG; Ramesh, V; Rao, AJ; Ravindranath, N1
Cheng, CH; Hu, C; Huang, B; Huang, X; Jiao, B; Liu, Z; Nagahama, Y; Wang, D; Wang, Z; Wu, F; Zhang, X; Zhang, Y; Zhou, L1
Blázquez, M; Navarro-Martín, L; Piferrer, F1
Inaji, H; Ishitobi, M; Komoike, Y; Koyama, H; Motomura, K; Nagase, H; Noguchi, S1
Amaral, C; Fernandes, PA; Ferreira Almeida, C; João Ramos, M; Oliveira, A; Teixeira, N1

Reviews

5 review(s) available for fadrozole and tamoxifen

ArticleYear
[Recent development of oral anti-cancer drugs for breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:3

    Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Administration Schedule; Fadrozole; Female; Floxuridine; Fluorouracil; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Survival Rate; Tamoxifen; Toremifene

1999
Drug and hormone interactions of aromatase inhibitors.
    Endocrine-related cancer, 1999, Volume: 6, Issue:2

    Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Enzyme Inhibitors; Estrogens; Fadrozole; Female; Humans; Letrozole; Male; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Sensitivity and Specificity; Tamoxifen; Triazoles

1999
[Endocrine therapy for advanced or recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:7

    Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Antagonists; Fadrozole; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Neoplasm Recurrence, Local; Tamoxifen; Toremifene

2001
A summary of second-line randomized studies of aromatase inhibitors.
    The Journal of steroid biochemistry and molecular biology, 2001, Volume: 79, Issue:1-5

    Topics: Aminoglutethimide; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Drug Tolerance; Enzyme Inhibitors; Estrogen Receptor Modulators; Fadrozole; Female; Humans; Letrozole; Megestrol Acetate; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles

2001
Estrogen receptor-positive (ER
    Biochemical pharmacology, 2020, Volume: 177

    Topics: Androstadienes; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogen Receptor alpha; Estrogen Receptor beta; Fadrozole; Female; Fulvestrant; Gene Expression; Humans; Molecular Targeted Therapy; Tamoxifen

2020

Trials

5 trial(s) available for fadrozole and tamoxifen

ArticleYear
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antigens; Breast Neoplasms; Chi-Square Distribution; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Gene Amplification; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Survival Analysis; Tamoxifen; Treatment Outcome

1995
Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.
    British journal of cancer, 1996, Volume: 73, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Confidence Intervals; Double-Blind Method; Fadrozole; Female; Flushing; Humans; Middle Aged; Nausea; Tamoxifen; Time Factors; Treatment Failure; Treatment Outcome

1996
A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Confidence Intervals; Disease-Free Survival; Enzyme Inhibitors; Fadrozole; Female; Humans; Middle Aged; Neoplasm Metastasis; Postmenopause; Prognosis; Prospective Studies; Survival Rate; Tamoxifen

1996
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Enzyme Inhibitors; Fadrozole; Female; Humans; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Tamoxifen

1996
[A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:11

    Topics: Aged; Aldosterone; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Fadrozole; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Postmenopause; Tamoxifen

2000

Other Studies

13 other study(ies) available for fadrozole and tamoxifen

ArticleYear
Disruption of ovarian development in alligator embryos treated with an aromatase inhibitor.
    General and comparative endocrinology, 1992, Volume: 86, Issue:1

    Topics: Alligators and Crocodiles; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Cyproterone; Cyproterone Acetate; Estradiol; Fadrozole; Female; Imidazoles; Male; Nitriles; Ovary; Tamoxifen; Testis

1992
Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:5

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrone; Fadrozole; Female; Follicle Stimulating Hormone; Imidazoles; Luteinizing Hormone; Mammary Neoplasms, Experimental; Nitriles; Prolactin; Rats; Rats, Inbred Strains; Tamoxifen

1990
CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo.
    Cancer research, 1988, Feb-15, Volume: 48, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Animals; Aromatase Inhibitors; Body Weight; Cell Line; Drug Screening Assays, Antitumor; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Rats; Tamoxifen

1988
Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
    Cancer research, 1995, Jul-15, Volume: 55, Issue:14

    Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Fadrozole; Female; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Organ Size; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles; Uterus

1995
Aromatase inhibitors in metastatic breast cancer.
    Seminars in oncology, 1996, Volume: 23, Issue:4 Suppl 9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles

1996
Fourteen-day oral combination dose toxicity study of CGS 16949 A (aromatase inhibitor) with 5-fluorouracil or tamoxifen in rats.
    The Journal of toxicological sciences, 1997, Volume: 22, Issue:1

    Topics: Administration, Oral; Animals; Aromatase Inhibitors; Blood Cell Count; Blood Chemical Analysis; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Eating; Fadrozole; Female; Fluorouracil; Organ Size; Ovary; Pituitary Gland; Rats; Rats, Inbred Strains; Tamoxifen; Urinalysis; Uterus; Vagina

1997
Regulation of plasma gonadotropin II secretion by sex steroids, aromatase inhibitors, and antiestrogens in the protandrous black porgy, Acanthopagrus schlegeli Bleeker.
    Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology, 2001, Volume: 129, Issue:2-3

    Topics: Animals; Aromatase; Aromatase Inhibitors; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Fadrozole; Feedback; Female; Gonadotropins, Pituitary; Gonads; Male; Perciformes; Steroids; Tamoxifen; Testosterone

2001
[An elderly woman with breast cancer and multiple liver metastasis that responded well to combination therapy of fadrozole and tamoxifen].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:13

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Fadrozole; Female; Humans; Liver Neoplasms; Tamoxifen

2001
Effects of sex steroids and their inhibitors on endocrine parameters and gender growth differences in Eurasian perch (Perca fluviatilis) juveniles.
    Steroids, 2005, Volume: 70, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Endocrine Glands; Estradiol; Fadrozole; Female; Flutamide; Gonadal Steroid Hormones; Growth Hormone; Hormone Antagonists; Male; Perches; Sex Characteristics; Structure-Activity Relationship; Tamoxifen; Testosterone

2005
Establishment of the need for oestrogen during implantation in non-human primates.
    Reproductive biomedicine online, 2007, Volume: 14, Issue:5

    Topics: Animals; Antibodies; Aromatase Inhibitors; Embryo Implantation; Estradiol; Estrogen Antagonists; Estrogens; Fadrozole; Female; Macaca radiata; Menstrual Cycle; Pregnancy; Pregnancy, Animal; Progesterone; Tamoxifen

2007
Molecular cloning of doublesex and mab-3-related transcription factor 1, forkhead transcription factor gene 2, and two types of cytochrome P450 aromatase in Southern catfish and their possible roles in sex differentiation.
    The Journal of endocrinology, 2007, Volume: 194, Issue:1

    Topics: Animals; Aromatase; Aromatase Inhibitors; Base Sequence; Catfishes; Cloning, Molecular; Estradiol; Estrogen Antagonists; Fadrozole; Female; Forkhead Transcription Factors; Gene Expression; Isoenzymes; Male; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; Sex Differentiation; Tamoxifen; Transcription Factors

2007
Masculinization of the European sea bass (Dicentrarchus labrax) by treatment with an androgen or aromatase inhibitor involves different gene expression and has distinct lasting effects on maturation.
    General and comparative endocrinology, 2009, Jan-01, Volume: 160, Issue:1

    Topics: Androgens; Animals; Aromatase Inhibitors; Bass; Cyproterone Acetate; Estradiol; Fadrozole; Female; Gonads; Male; Polymerase Chain Reaction; Receptors, Androgen; Sex Differentiation; Sexual Maturation; Tamoxifen

2009
Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.
    Oncology, 2010, Volume: 79, Issue:1-2

    Topics: Adult; Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Estrogen Receptor alpha; Estrogen Receptor beta; Fadrozole; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Nitriles; Phosphorylation; Predictive Value of Tests; Prognosis; Retrospective Studies; Serine; Tamoxifen; Triazoles

2010